Tasly Group is pleased to announce its official collaboration with STEMCELL-2026, an international conference dedicated to advancing global dialogue and innovation in stem cell research...
Read MoreThe FDA has announced a significant policy shift regarding animal testing requirements for certain drug categories, including monoclonal antibodies...
Read MoreThe Japanese Society for Regenerative Medicine has published important guidelines for ensuring safety in intravenous cell administration...
Read MoreA landmark approval in regenerative medicine as the FDA authorizes the first mesenchymal stromal cell therapy for treating a serious post-transplant complication...
Read More